Abstract
Innate lymphocytes — including natural killer cells and the recently discovered innate lymphoid cells — have crucial roles during infection, tissue injury and inflammation. Innate signals regulate the activation and homeostasis of innate lymphocytes. The contribution of the adaptive immune system to the coordination of innate lymphocyte responses is less well understood. In this Opinion article, we review our current understanding of the interactions between adaptive and innate lymphocytes, and propose a model in which T cells of the adaptive immune system function as antigen-specific sensors for the activation of innate lymphocytes to amplify and instruct local immune responses. We highlight the potential roles of regulatory and helper T cells in these processes, and discuss major questions in the emerging area of crosstalk between adaptive and innate lymphocytes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sanos, S. L. & Diefenbach, A. Innate lymphoid cells: from border protection to the initiation of inflammatory diseases. Immunol. Cell Biol. 91, 215–224 (2013).
Spits, H. et al. Innate lymphoid cells — a proposal for uniform nomenclature. Nature Rev. Immunol. 13, 145–149 (2013).
Walker, J. A., Barlow, J. L. & McKenzie, A. N. Innate lymphoid cells — how did we miss them? Nature Rev. Immunol. 13, 75–87 (2013).
Kirchberger, S. et al. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J. Exp. Med. 210, 917–931 (2013).
Fuchs, A. et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells. Immunity 38, 769–781 (2013).
Roediger, B. et al. Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nature Immunol. 14, 564–573 (2013).
Molofsky, A. B. et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J. Exp. Med. 210, 535–549 (2013).
Sitrin, J., Ring, A., Garcia, K. C., Benoist, C. & Mathis, D. Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2. J. Exp. Med. 210, 1153–1165 (2013).
Hams, E. et al. IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis. Proc. Natl Acad. Sci. USA 111, 367–372 (2014).
McHedlidze, T. et al. Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity 39, 357–371 (2013).
Chang, Y. J. et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nature Immunol. 12, 631–638 (2011).
Halim, T. Y. et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 40, 425–435 (2014).
Wilhelm, C. et al. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nature Immunol. 12, 1071–1077 (2011).
Feuerer, M., Shen, Y., Littman, D. R., Benoist, C. & Mathis, D. How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity 31, 654–664 (2009).
Lee, J. S. et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nature Immunol. 13, 144–151 (2012).
Monticelli, L. A. et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nature Immunol. 12, 1045–1054 (2011).
Swain, S. L., McKinstry, K. K. & Strutt, T. M. Expanding roles for CD4+ T cells in immunity to viruses. Nature Rev. Immunol. 12, 136–148 (2012).
Hepworth, M. R. et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 498, 113–117 (2013).
Waggoner, S. N., Cornberg, M., Selin, L. K. & Welsh, R. M. Natural killer cells act as rheostats modulating antiviral T cells. Nature 481, 394–398 (2012).
Qiu, J. et al. Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. Immunity 39, 386–399 (2013).
Lang, P. A. et al. Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proc. Natl Acad. Sci. USA 109, 1210–1215 (2012).
Gorski, S. A., Hahn, Y. S. & Braciale, T. J. Group 2 innate lymphoid cell production of IL-5 is regulated by NKT cells during influenza virus infection. PLoS Pathog. 9, e1003615 (2013).
Magri, G. et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nature Immunol. 15, 354–364 (2014).
Crome, S. Q., Lang, P. A., Lang, K. S. & Ohashi, P. S. Natural killer cells regulate diverse T cell responses. Trends Immunol. 34, 342–349 (2013).
Strowig, T. et al. Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-γ. PLoS Pathog. 4, e27 (2008).
Fehniger, T. A. et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 101, 3052–3057 (2003).
Luther, C., Warner, K. & Takei, F. Unique progenitors in mouse lymph node develop into CD127+ NK cells: thymus-dependent and thymus-independent pathways. Blood 117, 4012–4021 (2011).
Vosshenrich, C. A. et al. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nature Immunol. 7, 1217–1224 (2006).
Mirchandani, A. S. et al. Type 2 innate lymphoid cells drive CD4+ Th2 cell responses. J. Immunol. 192, 2442–2448 (2014).
Neill, D. R. et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464, 1367–1370 (2010).
Sutton, C. E. et al. Interleukin-1 and IL-23 induce innate IL-17 production from γδ T cells, amplifying Th17 responses and autoimmunity. Immunity 31, 331–341 (2009).
Cui, Y. et al. Major role of γδ T cells in the generation of IL-17+ uveitogenic T cells. J. Immunol. 183, 560–567 (2009).
Mortha, A. et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science 343, 1249288 (2014).
Withers, D. R. et al. Cutting edge: lymphoid tissue inducer cells maintain memory CD4 T cells within secondary lymphoid tissue. J. Immunol. 189, 2094–2098 (2012).
Aloisi, F. & Pujol-Borrell, R. Lymphoid neogenesis in chronic inflammatory diseases. Nature Rev. Immunol. 6, 205–217 (2006).
Peppa, D. et al. Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion. J. Exp. Med. 210, 99–114 (2013).
Gasteiger, G., Hemmers, S., Bos, P. D., Sun, J. C. & Rudensky, A. Y. IL-2-dependent adaptive control of NK cell homeostasis. J. Exp. Med. 210, 1179–1187 (2013).
Bevan, M. J. Helping the CD8+ T-cell response. Nature Rev. Immunol. 4, 595–602 (2004).
Soudja, S. M. et al. Memory-T-cell-derived interferon-γ instructs potent innate cell activation for protective immunity. Immunity 40, 974–988 (2014).
Josefowicz, S. Z., Lu, L. F. & Rudensky, A. Y. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531–564 (2012).
Ghiringhelli, F. et al. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner. J. Exp. Med. 202, 1075–1085 (2005).
Smyth, M. J. et al. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J. Immunol. 176, 1582–1587 (2006).
Ni, J., Miller, M., Stojanovic, A., Garbi, N. & Cerwenka, A. Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. J. Exp. Med. 209, 2351–2365 (2012).
Maury, S. et al. CD4+CD25+ regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after allogeneic hematopoietic stem cell transplantation. Sci. Transl Med. 2, 41ra52 (2010).
Barao, I. et al. Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells. Proc. Natl Acad. Sci. USA 103, 5460–5465 (2006).
Bihl, F. et al. Primed antigen-specific CD4+ T cells are required for NK cell activation in vivo upon Leishmania major infection. J. Immunol. 185, 2174–2181 (2010).
Sungur, C. M. et al. Murine natural killer cell licensing and regulation by T regulatory cells in viral responses. Proc. Natl Acad. Sci. USA 110, 7401–7406 (2013).
Lee, S. H., Fragoso, M. F. & Biron, C. A. Cutting edge: a novel mechanism bridging innate and adaptive immunity: IL-12 induction of CD25 to form high-affinity IL-2 receptors on NK cells. J. Immunol. 189, 2712–2716 (2012).
Terme, M. et al. Regulatory T cells control dendritic cell/NK cell cross-talk in lymph nodes at the steady state by inhibiting CD4+ self-reactive T cells. J. Immunol. 180, 4679–4686 (2008).
Su, H. C. et al. IL-2-dependent NK cell responses discovered in virus-infected beta 2-microglobulin-deficient mice. J. Immunol. 153, 5674–5681 (1994).
Henney, C. S., Kuribayashi, K., Kern, D. E. & Gillis, S. Interleukin-2 augments natural killer cell activity. Nature 291, 335–338 (1981).
Horowitz, A., Behrens, R. H., Okell, L., Fooks, A. R. & Riley, E. M. NK cells as effectors of acquired immune responses: effector CD4+ T cell-dependent activation of NK cells following vaccination. J. Immunol. 185, 2808–2818 (2010).
Horowitz, A. et al. Cross-talk between T cells and NK cells generates rapid effector responses to Plasmodium falciparum-infected erythrocytes. J. Immunol. 184, 6043–6052 (2010).
Pandiyan, P., Zheng, L., Ishihara, S., Reed, J. & Lenardo, M. J. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nature Immunol. 8, 1353–1362 (2007).
Fehniger, T. A. et al. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 26, 798–811 (2007).
Gasteiger, G. et al. IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells. J. Exp. Med. 210, 1167–1178 (2013).
Long, S. A. et al. Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function. Diabetes 61, 2340–2348 (2012).
Daussy, C. et al. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. J. Exp. Med. 211, 563–577 (2014).
Klose, C. S. et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157, 340–356 (2014).
Caligiuri, M. A. et al. Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. J. Clin. Invest. 91, 123–132 (1993).
Ito, S. et al. Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers. Mol. Ther. 22, 1388–1395 (2014).
Dalbeth, N. & Callan, M. F. A subset of natural killer cells is greatly expanded within inflamed joints. Arthritis Rheum. 46, 1763–1772 (2002).
Bauernhofer, T., Kuss, I., Henderson, B., Baum, A. S. & Whiteside, T. L. Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer. Eur. J. Immunol. 33, 119–124 (2003).
Schierloh, P. et al. Increased susceptibility to apoptosis of CD56dimCD16+ NK cells induces the enrichment of IFN-γ-producing CD56bright cells in tuberculous pleurisy. J. Immunol. 175, 6852–6860 (2005).
Klose, C. S. et al. A T-bet gradient controls the fate and function of CCR6−RORγt+ innate lymphoid cells. Nature 494, 261–265 (2013).
Sojka, D. K. et al. Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells. eLife 3, e01659 (2014).
Guo, L., Junttila, I. S. & Paul, W. E. Cytokine-induced cytokine production by conventional and innate lymphoid cells. Trends Immunol. 33, 598–606 (2012).
Mjosberg, J. et al. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 37, 649–659 (2012).
Cipolletta, D. et al. PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486, 549–553 (2012).
Busse, D. et al. Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments. Proc. Natl Acad. Sci. USA 107, 3058–3063 (2010).
Hofer, T., Krichevsky, O. & Altan-Bonnet, G. Competition for IL-2 between regulatory and effector T cells to chisel immune responses. Frontiers Immunol. 3, 268 (2012).
Scharton, T. M. & Scott, P. Natural killer cells are a source of interferon-γ that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178, 567–577 (1993).
Xu, W. & Di Santo, J. P. Taming the beast within: regulation of innate lymphoid cell homeostasis and function. J. Immunol. 191, 4489–4496 (2013).
Gebhardt, T., Mueller, S. N., Heath, W. R. & Carbone, F. R. Peripheral tissue surveillance and residency by memory T cells. Trends Immunol. 34, 27–32 (2013).
Shin, H. & Iwasaki, A. Tissue-resident memory T cells. Immunol. Rev. 255, 165–181 (2013).
Vezys, V. et al. Memory CD8 T-cell compartment grows in size with immunological experience. Nature 457, 196–199 (2009).
Welsh, R. M. & Selin, L. K. Attrition of memory CD8 T cells. Nature 459, E3–E4 (2009).
Huster, K. M. et al. Cutting edge: memory CD8 T cell compartment grows in size with immunological experience but nevertheless can lose function. J. Immunol. 183, 6898–6902 (2009).
Schenkel, J. M., Fraser, K. A., Vezys, V. & Masopust, D. Sensing and alarm function of resident memory CD8+ T cells. Nature Immunol. 14, 509–513 (2013).
Burzyn, D. et al. A special population of regulatory T cells potentiates muscle repair. Cell 155, 1282–1295 (2013).
Elliott, J. M. & Yokoyama, W. M. Unifying concepts of MHC-dependent natural killer cell education. Trends Immunol. 32, 364–372 (2011).
Gordon, S. M. et al. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 36, 55–67 (2012).
Peng, H. et al. Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J. Clin. Invest. 123, 1444–1456 (2013).
Constantinides, M. G., McDonald, B. D., Verhoef, P. A. & Bendelac, A. A committed precursor to innate lymphoid cells. Nature 508, 397–401 (2014).
Fathman, J. W. et al. Identification of the earliest natural killer cell-committed progenitor in murine bone marrow. Blood 118, 5439–5447 (2011).
Oliphant, C. J. et al. MHCII-mediated dialog between group 2 innate lymphoid cells and CD4+ T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity http://dx.doi.org/10.1016/j.immuni.2014.06.016 (2014).
Chan, C. W. et al. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nature Med. 12, 207–213 (2006).
Taieb, J. et al. A novel dendritic cell subset involved in tumor immunosurveillance. Nature Med. 12, 214–219 (2006).
Acknowledgements
A.Y.R. is supported by a US National Institutes of Health grant (R37 AI034206) and by the Ludwig Center at Memorial Sloan-Kettering Cancer Center (MSKCC), New York, USA. A.Y.R. is an investigator at the Howard Hughes Medical Center, New York, USA. G.G. is an Irvington Fellow of the Cancer Research Institute at MSKCC. The authors would like to thank J. C. Sun and the members of the Rudensky and Sun laboratories for helpful discussions. The authors would like to apologize to those investigators whose related work they were unable to discuss or quote owing to space limitations.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Glossary
- Alarmins
-
Prefabricated molecules (for example, interleukin-33) that are released upon cell and tissue damage by epithelial, stromal and myeloid cells to activate the immune system. The potency of some alarmins is regulated locally — for example, by proteolytic cleavage.
- Group 1 ILCs
-
(Group 1 innate lymphoid cells). This group of ILCs includes natural killer cells and ILC1s.
- ILC1
-
(Type 1 innate lymphoid cell). A subset of 'innate helper' cells that is characterized by expression of the transcription factor T-bet and the ability to produce interferon-γ in response to interleukin-12. ILC1s may have crucial functions during infection with intracellular pathogens.
- ILC2
-
(Type 2 innate lymphoid cell). A subset of 'innate helper' cells that is characterized by expression of the transcription factor GATA-binding protein 3 and the ability to produce interleukin-5 (IL-5) and IL-13 in response to IL-25 and IL-33. ILC2s have important roles during asthma and parasitic infection, as well as tissue homeostasis and fibrosis through the secretion of amphiregulin, for example.
- ILC3s
-
(Type 3 innate lymphoid cells). These 'innate helper' cells are characterized by expression of the transcription factor retinoic acid receptor-related orphan receptor-γt and the ability to produce interleukin-17 (IL-17) and IL-22 in response to IL-23. ILC3s have crucial functions during bacterial infection, particularly in the intestine. ILC3s may also present antigens and contribute to immune tolerance against microbial symbionts.
- Innate lymphoid cells
-
(ILCs). Recently discovered subsets of innate lymphocytes that seed peripheral organs, and produce 'helper' cytokines and tissue-protective factors that are crucial for barrier immunity.
- Lymphoid tissue inducer cell
-
(LTi cell). A subset of group 3 ILCs that are characterized by expression of the transcription factor retinoic acid receptor-related orphan receptor-γt and the production of lymphotoxin α1β1. LTi cells are required for the development of secondary lymphoid organs, and may have functions that are important during chronic inflammation and for T cell memory.
- Natural killer cells
-
(NK cells). Innate lymphocytes that can recognize and kill infected or cancerous cells. NK cells also produce interferon-γ and may have immunoregulatory functions.
Rights and permissions
About this article
Cite this article
Gasteiger, G., Rudensky, A. Interactions between innate and adaptive lymphocytes. Nat Rev Immunol 14, 631–639 (2014). https://doi.org/10.1038/nri3726
Published:
Issue Date:
DOI: https://doi.org/10.1038/nri3726
This article is cited by
-
Innate lymphoid cells and innate-like T cells in cancer — at the crossroads of innate and adaptive immunity
Nature Reviews Cancer (2023)
-
Identification of nafamostat mesylate as a selective stimulator of NK cell IFN-γ production via metabolism-related compound library screening
Immunologic Research (2022)
-
Serum free culture for the expansion and study of type 2 innate lymphoid cells
Scientific Reports (2021)
-
A follicular regulatory Innate Lymphoid Cell population impairs interactions between germinal center Tfh and B cells
Communications Biology (2021)
-
Association of neutrophil-to-lymphocyte ratio and risk of cardiovascular or all-cause mortality in chronic kidney disease: a meta-analysis
Clinical and Experimental Nephrology (2021)